Difference between revisions of "Rebimastat (BMS-275291)"
Jump to navigation
Jump to search
m |
m |
||
| Line 4: | Line 4: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Matrix metalloproteinase inhibitors]] | [[Category:Matrix metalloproteinase inhibitors]] | ||
| − | [[Category: | + | [[Category:Investigational drugs]] |
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 00:34, 3 December 2022
Mechanism of action
From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).